Meysam Soleimani

772 total citations
41 papers, 551 citations indexed

About

Meysam Soleimani is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meysam Soleimani has authored 41 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meysam Soleimani's work include RNA Interference and Gene Delivery (10 papers), MicroRNA in disease regulation (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Meysam Soleimani is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), MicroRNA in disease regulation (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Meysam Soleimani collaborates with scholars based in Iran, Germany and Denmark. Meysam Soleimani's co-authors include Massoud Saidijam, Reza Mahjub, Heidi Schwarzenbach, Fatemeh Nouri, Ali Jahanian‐Najafabadi, Amir Nili‐Ahmadabadi, Fatemeh Rahbarizadeh, Pouria Samadi, Griffin Pauli and Shyh‐Dar Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Meysam Soleimani

38 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meysam Soleimani Iran 14 266 97 86 75 72 41 551
Alireza Farasat Iran 14 351 1.3× 116 1.2× 37 0.4× 59 0.8× 40 0.6× 43 584
Fattah Sotoodehnejadnematalahi Iran 16 379 1.4× 139 1.4× 77 0.9× 49 0.7× 44 0.6× 65 687
Santosh Bashyal South Korea 14 256 1.0× 86 0.9× 53 0.6× 36 0.5× 92 1.3× 18 607
Ning Huang China 13 246 0.9× 70 0.7× 35 0.4× 49 0.7× 62 0.9× 36 588
Fengjiao Yuan China 14 232 0.9× 182 1.9× 24 0.3× 97 1.3× 87 1.2× 32 560
Kudelaidi Kuerban China 11 285 1.1× 79 0.8× 40 0.5× 92 1.2× 131 1.8× 18 544
Qiong Liu China 15 233 0.9× 288 3.0× 77 0.9× 69 0.9× 50 0.7× 34 816
Gang Yuan China 15 423 1.6× 116 1.2× 39 0.5× 81 1.1× 38 0.5× 30 863
Ik-Hwan Kim South Korea 17 328 1.2× 121 1.2× 87 1.0× 66 0.9× 80 1.1× 29 780
Jeffrey D. Konowalchuk Canada 9 290 1.1× 144 1.5× 66 0.8× 89 1.2× 72 1.0× 10 739

Countries citing papers authored by Meysam Soleimani

Since Specialization
Citations

This map shows the geographic impact of Meysam Soleimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meysam Soleimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meysam Soleimani more than expected).

Fields of papers citing papers by Meysam Soleimani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meysam Soleimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meysam Soleimani. The network helps show where Meysam Soleimani may publish in the future.

Co-authorship network of co-authors of Meysam Soleimani

This figure shows the co-authorship network connecting the top 25 collaborators of Meysam Soleimani. A scholar is included among the top collaborators of Meysam Soleimani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meysam Soleimani. Meysam Soleimani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alizamir, Meysam, Salim Heddam, Sungwon Kim, et al.. (2025). The development of an efficient artificial intelligence-based classification approach for colorectal cancer response to radiochemotherapy: deep learning vs. machine learning. Scientific Reports. 15(1). 62–62. 2 indexed citations
2.
Zali, Fatemeh, et al.. (2025). Enhancing chemotherapy for colorectal cancer: EGFR-conjugated ferritin nanocages for targeted doxorubicin delivery. Journal of drug targeting. 33(9). 1628–1638.
3.
Farmany, Abbas, et al.. (2024). Preparation and characterization of calcium-doped graphene oxide-chitosan Nanocarrier to enhance the gene delivery in MCF-7 cell line. Scientific Reports. 14(1). 27434–27434. 3 indexed citations
4.
Soleimani, Meysam, et al.. (2024). Novel engineered HER2 specific recombinant protein nanocages for targeted drug delivery. Molecular Biology Reports. 51(1). 773–773. 2 indexed citations
5.
Heidari, Fatemeh, et al.. (2023). The potential of monoclonal antibodies for colorectal cancer therapy. Medical Oncology. 40(9). 273–273.
6.
Saki, Ali Asghar, et al.. (2023). Approaches to determine the efficiency of novel 3-phytase from Klebsiella pneumoniae and commercial phytase in broilers from 1 to 14 d of age. Poultry Science. 102(11). 103014–103014. 4 indexed citations
7.
Ahmadyousefi, Yaghoub, Massoud Saidijam, Bagher Amirheidari, Fatemeh Rahbarizadeh, & Meysam Soleimani. (2022). A Novel Hyperthermostable Recombinant Protein Nanocage. Iranian Biomedical Journal. 26(6). 426–439. 3 indexed citations
10.
Taheri‬, Mohammad, Mohammad Reza Arabestani, Meysam Soleimani, et al.. (2022). Harnessing the Natural Toxic Metabolites in COVID-19. Evidence-based Complementary and Alternative Medicine. 2022. 1–7. 1 indexed citations
11.
Soleimani, Meysam, et al.. (2022). Evaluation of Ascorbic Acid Niosomes as Potential Detoxifiers in Oxidative Stress-induced HEK-293 Cells by Arsenic Trioxide. Iranian journal of pharmaceutical research. 21(1). e127038–e127038. 4 indexed citations
12.
Schwarzenbach, Heidi, et al.. (2022). MicroRNAs and their Implications in CD4+ T-cells,Oligodendrocytes and Dendritic Cells in Multiple SclerosisPathogenesis. Current Molecular Medicine. 23(7). 630–647. 6 indexed citations
13.
Lakpour, Niknam, et al.. (2021). Association of MTHFR C677T and MTRR A66G GenePolymorphisms with Iranian Male Infertility and Its Effect onSeminal Folate and Vitamin B12. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Shafaati, Maryam, Massoud Saidijam, Meysam Soleimani, et al.. (2021). A Brief Review on Dna Vaccines in the Era of COVID-19. Future Virology. 17(1). 49–66. 81 indexed citations
16.
Schwarzenbach, Heidi, et al.. (2019). Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease. Cell & Bioscience. 9(1). 91–91. 34 indexed citations
17.
Nili‐Ahmadabadi, Amir, et al.. (2019). Hepatoprotective potential and antioxidant activity of Allium tripedale in acetaminophen-induced oxidative damage. Research in Pharmaceutical Sciences. 14(6). 488–488. 21 indexed citations
18.
Soleimani, Meysam, et al.. (2019). A Bi-Functional Targeted P28-NRC Chimeric Protein with Enhanced Cytotoxic Effects on Breast Cancer Cell Lines.. PubMed. 18(2). 735–744. 18 indexed citations
19.
Soleimani, Meysam, Karim Mahnam, M. Hamid, Hojjat Sadeghi‐Aliabadi, & Ali Jahanian‐Najafabadi. (2016). Theoretical design of a new chimeric protein for the treatment of breast cancer.. PubMed. 11(3). 187–99. 15 indexed citations
20.
Soleimani, Meysam, et al.. (2010). Antioxidant and antimicrobial medicinal plants from Iran. Iranian journal of pharmaceutical research. 75–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026